Assessment of a Polygenic Risk Score in Screening for Prostate Cancer

Our BARCODE 1 study was published by New England Journal of Medicine and was led by the Institute of Cancer Research.  Professor Nora Pashayan has contributed to the study as a Co-investigator and Co-author.

This publication has attracted attention from several media outlets. Please find the corresponding links below for more details.

https://www.bbc.co.uk/news/articles/c98gg9qjn6ro

https://news.sky.com/story/new-at-home-spit-test-for-prostate-cancer-could-be-better-than-blood-test-study-suggests-13345537

https://www.independent.co.uk/news/health/prostate-cancer-spit-test-symptoms-uk-b2730406.html

https://www.telegraph.co.uk/news/2025/04/09/prostate-cancer-spit-test-brings-national-screening-closer/

https://www.standard.co.uk/news/health/prostate-cancer-saliva-test-b1221658.html